Skip to content

FOR LABORATORY RESEARCH USE ONLY — not for human or veterinary use, diagnosis, treatment, or cosmetic application. Buyers must be 21+ and legally permitted to purchase research chemicals in their jurisdiction.Intended-use statement →

Argireline Wholesale

Acetyl hexapeptide-8 — SNARE complex formation inhibitor for expression line research, manufacturer-direct

Product Identity

CAS Number616204-22-9
SequenceAc-Glu-Glu-Met-Gln-Arg-Arg-NH₂
Amino Acids6 (N-terminal acetyl, C-terminal amide)
Molecular FormulaC₃₄H₆₀N₁₄O₁₂S
Molecular Weight~889.0 Da
AppearanceWhite to off-white lyophilized powder
Purity≥99% by HPLC
SolubilitySoluble in sterile water; cosmetic formulation-compatible
Storage2–8°C, desiccated, protect from light

Available Configurations

ConfigurationContentBest For
Standard Kit10 mg × 10 vialsAnti-wrinkle formulation research; evaluation
Bulk Kit50 mg × 10 vialsProduct development; pilot production
CustomCustom mg × custom vialsOEM; private-label cosmetics

Research Background

Argireline (Acetyl Hexapeptide-8) is the most extensively studied anti-wrinkle peptide in cosmetic research. It functions as a competitive inhibitor of SNARE complex formation — the protein machinery that mediates synaptic vesicle docking and neurotransmitter release. By mimicking the N-terminal domain of SNAP-25, Argireline prevents formation of the ternary SNARE complex, reducing acetylcholine release at the neuromuscular junction. This produces a topical 'botulinum-mimetic' effect in research models.

Proposed Mechanisms

SNARE Complex DisruptionMimics SNAP-25 N-terminal → competes for ternary SNARE complex formation
Vesicle Docking InhibitionPrevents stable vesicle-membrane association → reduced exocytosis
ACh Release SuppressionDecreased quantal acetylcholine release at neuromuscular junction

Research Focus Areas

Expression Lines

SNARE complex inhibition → reduced vesicle docking → decreased ACh release

Forehead Wrinkles

Frontalis muscle relaxation in topical formulation models

Crow's Feet

Periorbital wrinkle severity reduction in split-face studies

Topical Botulinum-Mimetic

Non-invasive neurotransmitter modulation for cosmetic research

Quality Specifications

ParameterMethodCriterion
PurityHPLC at 214 nm, C18 column≥99.0% peak area
Identity (MW)ESI-MS~889.0 ± 1.0 Da
AppearanceVisual inspectionWhite to off-white powder
Peptide ContentAmino acid analysis≥80% net peptide
Residual MoistureKarl Fischer≤3%

Tiered Wholesale Pricing

Kit prices are quoted per specification — current list prices for peptide kits run from US$24 to US$339 per kit (10 vials); tiered volume discounts apply (see the tier table) — source:wholesale price list (PDF, updated 2026-08-08).

VolumeDiscountFor
1 kitList priceEvaluation; competitive analysis
5+ kits10% offInitial portfolio expansion
20+ kits20% offMid-size distributors
50+ kits30% offRegional distributors

FAQ

How does Argireline work in anti-wrinkle research?

Argireline mimics the N-terminal domain of SNAP-25, competitively inhibiting formation of the SNARE complex. Without a functional SNARE complex, synaptic vesicles cannot dock — ACh release is reduced, muscle fibers relax, and expression lines diminish in topical models.

What distinguishes Argireline from Snap-8?

Both target SNARE-mediated neurotransmitter release. Argireline prevents initial formation of the ternary SNARE complex. Snap-8 specifically targets the SNAP-25 binding site within an already-assembling complex. Argireline is the most-studied peptide in this class.

Is Argireline considered a 'topical Botox'?

In research terminology, Argireline is described as a 'topical botulinum-mimetic' because both reduce ACh release at the NMJ. However, mechanisms differ: botulinum toxin proteolytically cleaves SNARE proteins, while Argireline competitively inhibits SNARE assembly. Non-invasive topical delivery is the key distinction.

What is the optimal pH for Argireline in formulations?

Stable at pH 5.0–7.0. N-terminal acetylation and C-terminal amidation protect against exopeptidase degradation. Avoid strongly acidic (pH < 4) or alkaline (pH > 8) conditions.

What documentation is provided with Argireline?

Batch-specific COA: HPLC purity (≥99%), ESI-MS identity, peptide content by amino acid analysis. Commercial invoice and packing list included. Full analytical package for bulk orders.

All products are manufactured for laboratory research purposes only. Argireline is labeled FOR LABORATORY RESEARCH USE ONLY. Not for human or veterinary use, diagnosis, treatment, prophylaxis or any clinical, cosmetic, dietary or household application. Not a dietary supplement, pharmaceutical ingredient, cosmetic ingredient or approved drug substance. Buyers are responsible for verifying the legal status of importation and possession in their destination country.

Ready to Source Argireline?

Bulk pricing, tiered discounts up to 30%, COA with every order.

← Back to Cosmetic & Skin